Research Article

Identification of a New Prediction Model for Bladder Cancer Related to Immune Functions and Chemotherapy Using Gene Sets of Biological Processes

Figure 9

Evaluation of the influence of BPRG score on immunotherapeutic and chemotherapeutics efficacies for BLCA patients. (a) The expression of immune checkpoints in different BPRG score groups. (b) Sankey chart displays the distribution of responder and BPRG score. (c) Comparation of immunotherapy responder among two BPRG score groups. (d–f) Drug sensitivity analysis for gemcitabine, docetaxel, and cisplatin in BLCA patients belonging to high- and low-BPRG score groups. ; ; .
(a)
(b)
(c)
(d)
(e)
(f)